<DOC> 
<DOCNO>1040806_nation_story_3590863.utf8</DOCNO> 
<TEXT> 

The Telegraph - Calcutta : Nation
		 Friday, August 06, 2004 				 AIDS vaccine
																								New Delhi, Aug. 5: The first ever clinical trials on HIV/AIDS vaccines will begin in India by the end of the year, reports our special correspondent.																								Health secretary K.V.R. Prasad said the tests that could lead to a breakthrough in affordable anti-AIDS vaccine are likely to start in November. 																								The National AIDS Research Institute in Pune and the Tuberculosis Research Centre in Chennai have been chosen for conducting the tests. Currently, two vaccines are being targeted for trial: the Adeno-Associated Virus (AAV) vaccine and the Modified Vaccinia Ankara (MVA) vaccine.																								The Pune institute will begin the first phase of tests on the AAV vaccine that has been manufactured by the Targeted Genetics Corporation, a Seattle-based company. The trials will be part of a global exercise  field tests on the vaccine are underway in Germany and Belgium.																								The MVA vaccine will be tested in Chennai next year. Sekhar Chakrabarti, a biologist from the National Institute of Cholera and Enteric Diseases Calcutta has developed the vaccine manufactured by the Therion Biologic Corporation, another American company.																								Chakrabarti, a virus expert, has modified the vaccinia used for the small pox vaccine and used the strain to develop the AIDS serum. 																								Animal tests on Chakrabartis vaccine are currently on in the US. 
</TEXT> 
</DOC>